Mylan N.V. Business Finance Contracts & Agreements

51 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 2020 Indenture among Upjohn Finance B.V., Viatris Inc., Mylan Entities, and Citibank, N.A. as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture to Viatris Inc. Senior Notes Indenture (Guarantee Agreement) – Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., and The Bank of...
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Mylan Inc., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Third Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon, dated November 16, 2020
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and Citibank, N.A. (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Asset Purchase Agreement between Aspen Global Incorporated and Mylan Ireland Limited dated September 7, 2020
Purchase Agreements
Mylan N.V.
Pharmaceuticals
2020
Amendment to Term Credit Agreement among Mylan N.V., Guarantors, Lenders, and Goldman Sachs Bank USA (November 3, 2017)
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2017
Amendment to Revolving Credit Agreement among Mylan N.V., Bank of America, N.A., and Lenders (November 3, 2017)
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2017
Amendment No. 1 to Amended and Restated Receivables Purchase Agreement among Mylan Pharmaceuticals Inc., Mylan Securitization LLC, Victory Receivables Corporation, PNC Bank, and...
Purchase Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Third Supplemental Indenture to November 2013 Indenture among Mylan Inc., Mylan N.V., and The Bank of New York Mellon (March 12, 2015)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 1.800% and 2.600% Senior Notes between Mylan Inc., Mylan N.V., and The Bank of New York Mellon (March 12, 2015)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Second Supplemental Indenture to 3.125% Senior Notes Due 2023 between Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Third Supplemental Indenture to 2010 Indenture for 7.875% Senior Notes Due 2020 – Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
Fourth Supplemental Indenture to 3.750% Cash Convertible Notes Due 2015 – Mylan Inc., Mylan N.V., and The Bank of New York Mellon
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2015
First Supplemental Indenture among Mylan Inc., Utah Acquisition Sub Inc., Mylan II B.V., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Fourth Supplemental Indenture among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., and The Bank of New York Mellon, as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
First Supplemental Indenture among Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc., Viatris Inc., and The Bank of New York Mellon (Trustee)
Indenture Agreements
Mylan N.V.
Pharmaceuticals
2020
Amendment No. 2 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2020
Amendment No. 2, dated as of February 22, 2019, to the Term Credit Agreement dated as of November 22, 2016, among the Company, certain affiliates and subsidiaries of the Company...
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Amendment No. 1, dated February 22, 2019, to the Revolving Credit Agreement dated as of July 27, 2018, among Mylan Inc., as borrower, Mylan N.V., as a guarantor, the other...
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2019
Revolving Credit Agreement among Mylan Inc., Mylan N.V., Bank of America, N.A., and Lenders (July 27, 2018)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Indenture for 2.125% Senior Notes Due 2025 between Mylan Inc., Mylan N.V., and Citibank, N.A., London Branch
Indenture Agreements
Mylan N.V.
Pharmaceuticals
PA
2018
Mylan Inc. Registration Rights Agreement for $1.5 Billion Senior Notes (2028 & 2048)
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Indenture for Mylan Inc. 4.550% Senior Notes Due 2028 and 5.200% Senior Notes Due 2048 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2018
Indenture for Mylan N.V. Floating Rate Senior Notes Due 2020 with Citibank, N.A., London Branch as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
PA
2017
Waiver Letter Regarding Accelerated Vesting Upon Retirement for Restricted Stock Units (Mylan N.V.)
Waiver Agreements
Mylan N.V.
Pharmaceuticals
2017
Mylan N.V. Registration Rights Agreement for $6.5 Billion Senior Notes (2019–2046) with Initial Purchasers
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Indenture for Mylan N.V. Senior Notes Due 2019, 2021, 2026, and 2046 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 2 to Term Credit Agreement among Mylan Inc., Mylan N.V., PNC Bank, and Lenders
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 3 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Amendment No. 3 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Bank of America, N.A., and Lenders
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2016
Mylan N.V. Registration Rights Agreement for $1 Billion Senior Notes (2018 & 2020)
Registration Rights Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Indenture for Mylan N.V. 3.000% Senior Notes Due 2018 and 3.750% Senior Notes Due 2020 with The Bank of New York Mellon as Trustee
Indenture Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 1 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and PNC Bank, N.A.
Modification Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Revolving Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Term Credit Agreement among Mylan Inc., Mylan N.V., Lenders, and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Term Credit Agreement among Mylan Inc., Mylan N.V., PNC Bank, and Other Lenders (July 15, 2015)
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Amendment No. 2 to Bridge Credit Agreement among Mylan N.V., Lenders, and Goldman Sachs Bank USA
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015
Additional Credit Extension Amendment to Revolving Credit Agreement among Mylan Inc., Mylan N.V., ING Bank N.V., and Bank of America, N.A.
Credit Agreements
Mylan N.V.
Pharmaceuticals
NY
2015